Search

Your search keyword '"Devogelaer, Jean-Pierre"' showing total 757 results
Start Over Author "Devogelaer, Jean-Pierre"
757 results on '"Devogelaer, Jean-Pierre"'

3. Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget’s disease of bone

Author

Phillips, Jonathan, primary, Subedi, Deepak, additional, Lewis, Steff C, additional, Keerie, Catriona, additional, Cronin, Owen, additional, Porteous, Mary, additional, Moore, David, additional, Cetnarskyj, Roseanne, additional, Ranganath, Lakshminarayan, additional, Selby, Peter L, additional, Turgut, Tolga, additional, Hampson, Geeta, additional, Chandra, Rama, additional, Ho, Shu, additional, Tobias, Jon, additional, Young-Min, Steven, additional, McKenna, Malachi J, additional, Crowley, Rachel K, additional, Fraser, William D, additional, Tang, Jonathan C Y, additional, Gennari, Luigi, additional, Nuti, Rannuccio, additional, Brandi, Maria Luisa, additional, Del Pino-Montes, Javier, additional, Devogelaer, Jean-Pierre, additional, Durnez, Anne, additional, Isaia, Giovanni Carlo, additional, Di Stefano, Marco, additional, Guanabens, Nuria, additional, Blanch Rubio, Josep, additional, Seibel, Markus J, additional, Walsh, John P, additional, Rea, Sarah L, additional, Kotowicz, Mark A, additional, Nicholson, Geoffrey C, additional, Duncan, Emma L, additional, Major, Gabor, additional, Horne, Anne, additional, Gilchrist, Nigel, additional, and Ralston, Stuart H, additional

Published
2023
Full Text
View/download PDF

10. Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Author

Cooper, Cyrus, Bardin, Thomas, Brandi, Maria-Luisa, Cacoub, Patrice, Caminis, John, Civitelli, Roberto, Cutolo, Maurizio, Dere, Willard, Devogelaer, Jean-Pierre, Diez-Perez, Adolfo, Einhorn, Thomas A., Emonts, Patrick, Ethgen, Olivier, Kanis, John A., Kaufman, Jean-Marc, Kvien, Tore K., Lems, Willem F., McCloskey, Eugene, Miossec, Pierre, Reiter, Susanne, Ringe, Johann, Rizzoli, René, Saag, Kenneth, and Reginster, Jean-Yves

Published
2016
Full Text
View/download PDF

11. Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Author

Rozenberg, Serge, Body, Jean-Jacques, Bruyère, Olivier, Bergmann, Pierre, Brandi, Maria Luisa, Cooper, Cyrus, Devogelaer, Jean-Pierre, Gielen, Evelien, Goemaere, Stefan, Kaufman, Jean-Marc, Rizzoli, René, and Reginster, Jean-Yves

Published
2016
Full Text
View/download PDF

12. Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty

Author

Arden, Nigel, Richette, Pascal, Cooper, Cyrus, Bruyère, Olivier, Abadie, Eric, Branco, Jaime, Brandi, Maria Luisa, Berenbaum, Francis, Clerc, Cécile, Dennison, Elaine, Devogelaer, Jean-Pierre, Hochberg, Marc, D’Hooghe, Pieter, Herrero-Beaumont, Gabriel, Kanis, John A., Laslop, Andrea, Leblanc, Véronique, Maggi, Stefania, Mautone, Giuseppe, Pelletier, Jean-Pierre, Petit-Dop, Florence, Reiter-Niesert, Susanne, Rizzoli, René, Rovati, Lucio, Tajana Messi, Eleonora, Tsouderos, Yannis, Martel-Pelletier, Johanne, and Reginster, Jean-Yves

Published
2015
Full Text
View/download PDF

13. Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

Author

Bruyère, Olivier, Cooper, Cyrus, Arden, Nigel, Branco, Jaime, Brandi, Maria Luisa, Herrero-Beaumont, Gabriel, Berenbaum, Francis, Dennison, Elaine, Devogelaer, Jean-Pierre, Hochberg, Marc, Kanis, John, Laslop, Andrea, McAlindon, Tim, Reiter, Susanne, Richette, Pascal, Rizzoli, René, and Reginster, Jean-Yves

Published
2015
Full Text
View/download PDF

21. Health Technology Assessment in Osteoporosis

Author

Hiligsmann, Mickael, Kanis, John A., Compston, Juliet, Cooper, Cyrus, Flamion, Bruno, Bergmann, Pierre, Body, Jean-Jacques, Boonen, Steven, Bruyere, Olivier, Devogelaer, Jean-Pierre, Goemaere, Stefan, Kaufman, Jean-Marc, Rozenberg, Serge, and Reginster, Jean-Yves

Published
2013
Full Text
View/download PDF

23. Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse

Author

UCL - SSS/IREC/MORF - Pôle de Morphologie, Cardinal, Mickaël, Chretien, Antoine, Roels, Thomas, Lafont, Sébastien, Ominsky, Michael S., Devogelaer, Jean-Pierre, Manicourt, Daniel, Behets Wydemans, Catherine, UCL - SSS/IREC/MORF - Pôle de Morphologie, Cardinal, Mickaël, Chretien, Antoine, Roels, Thomas, Lafont, Sébastien, Ominsky, Michael S., Devogelaer, Jean-Pierre, Manicourt, Daniel, and Behets Wydemans, Catherine

Abstract

Osteogenesis imperfecta (OI), which is most often due to a collagen type 1 gene mutation, is characterized by low bone density and bone fragility. In OI patients, gender-related differences were reported, but data in the literature are not convergent. We previously observed that sclerostin antibody (Scl-Ab), which stimulates osteoblast Wnt pathway via sclerostin inactivation, improved spine and long-bone parameters and biomechanical strength in female oim/oim mice, a validated model of human type 3 OI. Here, we wanted to highlight the effect of Scl-Ab on male oim/oim bones in order to identify a possible distinct therapeutic effect from that observed in females. According to the same protocol as our previous study with female mice, male wild-type (Wt) and oim/oim mice received vehicle or Scl-Ab from 5 to 14 weeks of age. Clinimetric and quantitative bone parameters were studied using X-rays, peripheral quantitative computed tomography, microradiography, and dynamic histomorphometry and compared to those of females. Contrary to Wt mice, male oim/oim had significantly lower weight, snout–sacrum length, and bone mineral content than females at 5 weeks. No significant difference in these clinimetric parameters was observed at 14 weeks, whereas male oim showed significantly more long-bone fractures than females. Scl-Ab improved bone mineral density and bone volume/total volume ratio (BV/TV) of vertebral body in Wt and oim/oim, without significant difference between male and female at 14 weeks. Male vehicle oim/oim had a significantly lower cortical thickness (Ct.Th) and BV/TV of tibial diaphysis than female and showed a higher number of fractures at 14 weeks. Scl-Ab increased midshaft periosteal apposition rate in such a way that tibial Ct.Th of male oim/oim was not significantly different from the female one at 14 weeks. The number of fractures was lower in male than female oim/oim after 14 weeks of Scl-Ab treatment, but this difference was not significant. Nevertheless

Published
2021

27. Characteristics of early Paget's disease in SQSTMI mutation carriers:baseline analysis of the ZIPP study cohort

Author

Cronin, Owen, Subedi, Deepak, Forsyth, Laura, Goodman, Kirsteen, Lewis, Steff C., Keerie, Catriona, Walker, Allan, Porteous, Mary, Cetnarskyj, Roseanne, Ranganath, Lakshminarayan R., Selby, Peter, Hampson, Geeta, Chandra, Rama, Ho, Shu, Tobias, Jonathan H, Young-Min, Steven, McKenna, Malachi J., Crowley, Rachel K., Fraser, William D, Tang, Jonathan, Gennari, Luigi, Nuti, Rannuccio, Brandi, Maria Luisa, Del Pino-Montes, Javier, Devogelaer, Jean-Pierre, Durnez, Anne, Isaia, Giovanni Carlo, Di Stefano, Marco, Rubio, Josep Blanch, Guañabens, Núria, Seibel, Markus J., Walsh, John P, Kotowicz, Mark A., Nicholson, Geoffrey C., Duncan, Emma L, Major, Gabor, Horne, Anne, Gilchrist, Nigel L., and Ralston, Stuart H.

Subjects
SQSTM1, genetics, Paget’s disease of bone, radionuclide imaging
Abstract

Objectives: Mutations in SQSTM1 are strongly associated with Paget’s disease of bone (PDB) but little is known about the clinical characteristics of those with early disease. Methods: Radionuclide bone scans, biochemical markers of bone turnover and clinical characteristics were analysed in SQSTM1 mutation carriers who took part in the Zoledronic acid in the Prevention of Paget’s disease (ZiPP) study. Results: We studied 222 individuals of whom 54.9% were female with average (± sem) age of 50.1± 0.6 years. Twelve SQSTM1 mutations were observed, including p.Pro392Leu which was present in 141/222 (63.5%) subjects. Bone scan examination revealed evidence of PDB in 20 subjects (9.0%) of which 9 (50%) had a single affected site. Participants with lesions were older than those without lesions but the difference was not significant (53.6 ± 9.1 vs. 49.8 ± 8.9, p=0.07). The mean age of participants with lesions was not significantly different from the age at which their parents were diagnosed with PDB (55 years vs. 59 years, p=0.25). All individuals with lesions were asymptomatic. Serum concentrations of total alkaline phosphatase (ALP) normalised to the upper limit of normal in each centre were higher in those with lesions (0.75 ± 0.69 vs 0.42 ± 0.29; pConclusions: Asymptomatic PDB is present in about 9% of SQSTM1 mutation carriers by the fifth decade. Further follow up of this cohort will provide important information on the natural history of early PDB and its response to treatment

Published
2020

30. Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort

Author

Cronin, Owen, Subedi, Deepak, Forsyth, Laura, Goodman, Kirsteen, Lewis, Steff C., Keerie, Catriona, Walker, Allan, Porteous, Mary, Cetnarskyj, Roseanne, Ranganath, Lakshminarayan R., Selby, Peter L., Hampson, Geeta, Chandra, Rama, Ho, Shu, Tobias, Jon H., Young-Min, Steven A., McKenna, Malachi J., Crowley, Rachel K., Fraser, William D., Tang, Jonathan, Gennari, Luigi, Nuti, Rannuccio, Brandi, Maria Luisa, del Pino-Montes, Javier, Devogelaer, Jean Pierre, Durnez, Anne, Isaia, Giovanni Carlo, Di Stefano, Marco, Rubio, Josep Blanch, Guanabens, Nuria, Seibel, Markus J., Walsh, John P., Kotowicz, Mark A., Nicholson, Geoffrey C., Duncan, Emma L., Major, Gabor, Horne, Anne, Gilchrist, Nigel L., Ralston, Stuart H., Cronin, Owen, Subedi, Deepak, Forsyth, Laura, Goodman, Kirsteen, Lewis, Steff C., Keerie, Catriona, Walker, Allan, Porteous, Mary, Cetnarskyj, Roseanne, Ranganath, Lakshminarayan R., Selby, Peter L., Hampson, Geeta, Chandra, Rama, Ho, Shu, Tobias, Jon H., Young-Min, Steven A., McKenna, Malachi J., Crowley, Rachel K., Fraser, William D., Tang, Jonathan, Gennari, Luigi, Nuti, Rannuccio, Brandi, Maria Luisa, del Pino-Montes, Javier, Devogelaer, Jean Pierre, Durnez, Anne, Isaia, Giovanni Carlo, Di Stefano, Marco, Rubio, Josep Blanch, Guanabens, Nuria, Seibel, Markus J., Walsh, John P., Kotowicz, Mark A., Nicholson, Geoffrey C., Duncan, Emma L., Major, Gabor, Horne, Anne, Gilchrist, Nigel L., and Ralston, Stuart H.

Abstract

Mutations in SQSTM1 are strongly associated with Paget's disease of bone (PDB), but little is known about the clinical characteristics of those with early disease. Radionuclide bone scans, biochemical markers of bone turnover, and clinical characteristics were analyzed in SQSTM1 mutation carriers who took part in the Zoledronic acid in the Prevention of Paget's disease (ZiPP) study. We studied 222 individuals, of whom 54.9% were female, with mean ± SE age of 50.1 ± 0.6 years. Twelve SQSTM1 mutations were observed, including p.Pro392Leu, which was present in 141 of 222 (63.5%) subjects. Bone scan examination revealed evidence of PDB in 20 subjects (9.0%), ten of whom (50%) had a single affected site. Participants with lesions were older than those without lesions but the difference was not significant (53.6 ± 9.1 versus 49.8 ± 8.9; p =.07). The mean age of participants with lesions was not significantly different from the age at which their parents were diagnosed with PDB (55 years versus 59 years, p =.17). All individuals with lesions were asymptomatic. Serum concentrations of total alkaline phosphatase (ALP) normalized to the upper limit of normal in each center were higher in those with lesions (0.75 ± 0.69 versus 0.42 ± 0.29 arbitary units; p <.0001). Similar findings were observed for other biochemical markers of bone turnover, but the sensitivity of ALP and other markers in detecting lesions was poor. Asymptomatic PDB is present in about 9% of SQSTM1 mutation carriers by the fifth decade. Further follow-up of this cohort will provide important information on the natural history of early PDB and its response to treatment.

Published
2020

31. Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort.

Author

UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales, UCL - (SLuc) Service de rhumatologie, Cronin, Owen, Subedi, Deepak, Forsyth, Laura, Goodman, Kirsteen, Lewis, Steff C, Keerie, Catriona, Walker, Allan, Porteous, Mary, Cetnarskyj, Roseanne, Ranganath, Lakshminarayan R, Selby, Peter L, Hampson, Geeta, Chandra, Rama, Ho, Shu, Tobias, Jon H, Young-Min, Steven A, McKenna, Malachi J, Crowley, Rachel K, Fraser, William D, Tang, Jonathan, Gennari, Luigi, Nuti, Rannuccio, Brandi, Maria-Luisa, Del Pino-Montes, Javier, Devogelaer, Jean-Pierre, Durnez, Anne, Isaia, Giovanni Carlo, Di Stefano, Marco, Rubio, Josep Blanch, Guanabens, Nuria, Seibel, Markus J, Walsh, John P, Kotowicz, Mark A, Nicholson, Geoffrey C, Duncan, Emma L, Major, Gabor, Horne, Anne, Gilchrist, Nigel L, Ralston, Stuart H, UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales, UCL - (SLuc) Service de rhumatologie, Cronin, Owen, Subedi, Deepak, Forsyth, Laura, Goodman, Kirsteen, Lewis, Steff C, Keerie, Catriona, Walker, Allan, Porteous, Mary, Cetnarskyj, Roseanne, Ranganath, Lakshminarayan R, Selby, Peter L, Hampson, Geeta, Chandra, Rama, Ho, Shu, Tobias, Jon H, Young-Min, Steven A, McKenna, Malachi J, Crowley, Rachel K, Fraser, William D, Tang, Jonathan, Gennari, Luigi, Nuti, Rannuccio, Brandi, Maria-Luisa, Del Pino-Montes, Javier, Devogelaer, Jean-Pierre, Durnez, Anne, Isaia, Giovanni Carlo, Di Stefano, Marco, Rubio, Josep Blanch, Guanabens, Nuria, Seibel, Markus J, Walsh, John P, Kotowicz, Mark A, Nicholson, Geoffrey C, Duncan, Emma L, Major, Gabor, Horne, Anne, Gilchrist, Nigel L, and Ralston, Stuart H

Abstract

Mutations in SQSTM1 are strongly associated with Paget's disease of bone (PDB), but little is known about the clinical characteristics of those with early disease. Radionuclide bone scans, biochemical markers of bone turnover, and clinical characteristics were analyzed in SQSTM1 mutation carriers who took part in the Zoledronic acid in the Prevention of Paget's disease (ZiPP) study. We studied 222 individuals, of whom 54.9% were female, with mean ± SE age of 50.1 ± 0.6 years. Twelve SQSTM1 mutations were observed, including p.Pro392Leu, which was present in 141 of 222 (63.5%) subjects. Bone scan examination revealed evidence of PDB in 20 subjects (9.0%), ten of whom (50%) had a single affected site. Participants with lesions were older than those without lesions but the difference was not significant (53.6 ± 9.1 versus 49.8 ± 8.9; p = .07). The mean age of participants with lesions was not significantly different from the age at which their parents were diagnosed with PDB (55 years versus 59 years, p = .17). All individuals with lesions were asymptomatic. Serum concentrations of total alkaline phosphatase (ALP) normalized to the upper limit of normal in each center were higher in those with lesions (0.75 ± 0.69 versus 0.42 ± 0.29 arbitary units; p < .0001). Similar findings were observed for other biochemical markers of bone turnover, but the sensitivity of ALP and other markers in detecting lesions was poor. Asymptomatic PDB is present in about 9% of SQSTM1 mutation carriers by the fifth decade. Further follow-up of this cohort will provide important information on the natural history of early PDB and its response to treatment. © 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research.

Published
2020

32. Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

Author

Bruyère, Olivier, Cooper, Cyrus, Arden, Nigel, Branco, Jaime, Brandi, Maria Luisa, Herrero-Beaumont, Gabriel, Berenbaum, Francis, Dennison, Elaine, Devogelaer, Jean-Pierre, Hochberg, Marc, Kanis, John, Laslop, Andrea, McAlindon, Tim, Reiter, Susanne, Richette, Pascal, Rizzoli, René, and Reginster, Jean-Yves

Published
2017
Full Text
View/download PDF

38. Ten years' experience with alendronate for osteoporosis in postmenopausal women

Author

Bone, Henry G., Hosking, David, Devogelaer, Jean-Pierre, Tucci, Joseph R., Emkey, Ronald D., Tonino, Richard P., Rodriguez-Portales, Jose Adolfo, Dowms, Robert W., Gupta, Jayanti, Santora, Arthur C., and Liberman, Uri A.

Subjects
Alendronate -- Usage, Alendronate -- Patient outcomes, Osteoporosis -- Research, Osteoporosis -- Care and treatment, Osteoporosis -- Patient outcomes, Postmenopausal women -- Research, Postmenopausal women -- Care and treatment
Abstract

The results of a multinational randomized, double-blind study, in which postmenopausal women with osteoporosis were treated with alendronate for unto 10 years, are reported. The discontinuation of alendronate resulted in a gradual loss of effect, as measured by bone density and biochemical markers of bone remodeling.

Published
2004

43. Intravenous zoledronic acid in postmenopausal women with low bone mineral density

Author

Reid, Ian R., Brown, Jacques P., Burckhardt, Peter, Horowitz, Zebulun, Richardson, Peter, Trechsel, Ulrich, Widmer, Albert, Devogelaer, Jean-Pierre, Kaufman, Jean-Marc, Jaeger, Philippe, Body, Jean-Jacques, and Meunier, Pierre J.

Subjects
Osteoporosis -- Drug therapy, Diphosphonates -- Dosage and administration
Abstract

Giving postmenopausal women an intravenous infusion of a drug called zoledronic acid appears to be as effective as other similar drugs used to treat osteoporosis that must be taken orally every day. This is important because these drugs, which are called bisphosphonates, have side effects that could be minimized if they are only taken once a year.

Published
2002

44. Characteristics of Early Paget's Disease inSQSTM1Mutation Carriers: Baseline Analysis of theZiPPStudy Cohort

Author

Cronin, Owen, primary, Subedi, Deepak, additional, Forsyth, Laura, additional, Goodman, Kirsteen, additional, Lewis, Steff C, additional, Keerie, Catriona, additional, Walker, Allan, additional, Porteous, Mary, additional, Cetnarskyj, Roseanne, additional, Ranganath, Lakshminarayan R, additional, Selby, Peter L, additional, Hampson, Geeta, additional, Chandra, Rama, additional, Ho, Shu, additional, Tobias, Jon H, additional, Young‐Min, Steven A, additional, McKenna, Malachi J, additional, Crowley, Rachel K, additional, Fraser, William D, additional, Tang, Jonathan, additional, Gennari, Luigi, additional, Nuti, Rannuccio, additional, Brandi, Maria‐Luisa, additional, Pino‐Montes, Javier, additional, Devogelaer, Jean‐Pierre, additional, Durnez, Anne, additional, Isaia, Giovanni Carlo, additional, Di Stefano, Marco, additional, Rubio, Josep Blanch, additional, Guanabens, Nuria, additional, Seibel, Markus J, additional, Walsh, John P, additional, Kotowicz, Mark A, additional, Nicholson, Geoffrey C, additional, Duncan, Emma L, additional, Major, Gabor, additional, Horne, Anne, additional, Gilchrist, Nigel L, additional, and Ralston, Stuart H, additional

Published
2020
Full Text
View/download PDF

46. Contributors

Author

Adachi, Jonathan (Rick), primary, Åkesson, Kristina, additional, Boutsen, Yves, additional, Burr, David B., additional, Cooper, Cyrus, additional, Dennison, Elaine, additional, Devogelaer, Jean-Pierre, additional, Faulkner, Kenneth G., additional, Garnero, Patrick, additional, Geusens, Piet P.M.M., additional, Handelsman, David J., additional, Harvey, Nicholas, additional, Hochberg, Marc C., additional, Humphrey, Mary Beth, additional, Jones, Graeme, additional, Kulik, Dina, additional, Lane, Nancy E., additional, Liu, Peter Y., additional, Majumdar, Sharmila, additional, Maalouf, Naim M., additional, Manicourt, Daniel Henri, additional, Meier, Christian, additional, Miller, Paul D., additional, Nakamura, Mary C., additional, Reid, Ian R., additional, Romas, Evange, additional, Russell, Graham, additional, Sambrook, Philip N., additional, Seibel, Markus J., additional, Shane, Elizabeth, additional, Shefelbine, Sandra J., additional, Silverman, Stuart L., additional, Sinigaglia, Luigi, additional, Spector, Tim D., additional, Turner, Charles H., additional, Varenna, Massimo, additional, Westlake, Sarah, additional, Williams, Frances M.K., additional, and Woolf, Anthony D., additional

Published
2006
Full Text
View/download PDF

48. Contributors

Author

Åkesson, Kristina, primary, Alatalo, Sari L., additional, Allison, Susan J., additional, Aly, Ziyad Al, additional, Baldock, Paul A., additional, Bilezikian, John P., additional, Binkley, Neil, additional, Body, Jean-Jacques, additional, Bonjour, Jean-Philippe, additional, Boskey, Adele L., additional, Bouillon, Roger, additional, Brixen, Kim, additional, Bruckner, Peter, additional, Carmeliet, Geert, additional, Clark, Ian M, additional, Croucher, Peter, additional, Delmas, Pierre D., additional, Dempster, David W., additional, Devogelaer, Jean-Pierre, additional, Drezner, Marc K., additional, Eastell, Richard, additional, Eelen, Guy, additional, Eriksen, Erik Fink, additional, Fitzpatrick, Lorraine A., additional, Fuleihan, Ghada El-Hajj, additional, Gardiner, Edith M., additional, Garnero, Patrick, additional, Gay, Renate E., additional, Gay, Steffen, additional, Glorieux, Francis H., additional, Goldring, Mary B., additional, Goldring, Steven R., additional, Goltzman, David, additional, González, Esther A., additional, Grauer, Andreas, additional, Gundberg, Caren M., additional, Hardingham, Tim, additional, Harrison, John R., additional, Heinegård, Dick, additional, Helfrich, M.H., additional, Herzog, Herbert, additional, Horton, M.A., additional, Hulley, Philippa, additional, Jüppner, Harald, additional, Kaija, Helena, additional, Khosla, S., additional, Kraenzlin, Marius E., additional, Kream, Barbara E., additional, Kulak, Carolina A. Moreira, additional, van Leeuwen, Johannes P.T.M., additional, Lensmeyer, Gary L., additional, Lian, Jane B., additional, Lorenzo, Joseph A., additional, Lorenzo, Pilar, additional, Maes, Christa, additional, Manicourt, Daniel-Henri, additional, von der Mark, Klaus, additional, Martin, Kevin J., additional, Martin, T. John, additional, Meier, Christian, additional, van Meurs, Joyce B.J., additional, Millán, José Luis, additional, Monroe, David G., additional, Mulder, Jean E., additional, Murphy, Gillian, additional, Naylor, Kim E., additional, Neidhart, Michel, additional, Nguyen, Tuan V., additional, Nishimoto, Satoru K., additional, Patrikainen, Lila O.T., additional, Pols, Huibert A.P., additional, Raisz, Lawrence G., additional, Ralston, Stuart, additional, Rauch, Frank, additional, Reid, Ian R., additional, Risteli, Juha, additional, Risteli, Leila, additional, Rivadeneira, Fernando, additional, Rizzoli, René, additional, Robins, Simon P., additional, Rosen, Clifford J., additional, Rubin, Mishaela R., additional, Russell, Graham, additional, Saxne, Tore, additional, Schmidt-Gayk, Heinrich, additional, Seeman, Ego, additional, Seibel, Markus J., additional, Shane, Elizabeth, additional, Silverberg, Shonni J., additional, Simkin, Peter A., additional, Sims, Natalie A., additional, Siris, Ethel, additional, Spelsberg, Thomas C., additional, Stein, Gary S., additional, Thonar, Eugene J.-M. A., additional, Uitterlinden, André G., additional, Väänänen, H. Kalervo, additional, Verstuyf, Annemieke, additional, Vihko, Pirkko T., additional, Whyte, Michael P., additional, and Zhou, Hua, additional

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results